Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 20, Issue 3, 2009, Pages

  Mittal, Rahul ^a,b   Sharma, Saroj ^b   Chhibber, Sanjay ^b   Harjai, Kusum ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b PANJAB UNIVERSITY   (India)

Author keywords

Biofilms; IL 1 ; Neutrophil recruitment; Pseudomonas aeruginosa; Pyelonephritis; TNF

Indexed keywords

GLUTATHIONE; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BIOFILM; CONTROLLED STUDY; CYTOKINE PRODUCTION; EVALUATION; FEMALE; HOST; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PLANKTON; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; TISSUE INJURY;

EID: 70349720930     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/810791     Document Type: Article

References (61)

1. Rushton HG. Urinary tract infections in children: Epidemiology, evaluation, and management. Pediatr Clin North Am 1997;44:1133-1169 (Pubitemid 27424169)
2. Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 1994;70:111-115
3. Ott U, Busch M, Steiner T, et al. Renal failure, sepsis, and bilateral kidney tumors. Xanthogranulomatous pyelonephritis. Kidney Int 2008;73:787-788 (Pubitemid 351323260)
4. Zasloff M. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 2007;18:2810-2816 (Pubitemid 350058386)
5. Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 1983;5:279-313.
6. Lyczak JB, Cannon C, Pier GB. Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microb Infect 2000;2:1051-1060
7. Gómez MI, Prince A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 2007;7:244-251
8. Engel J, Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 2009;12:61-66
9. Girard G, Bloemberg GV. Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa. Future Microbiol 2008;3:97-106.
10. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005;171:1209-1223
11. Mittal R, Khandwaha RK, Gupta V, Mittal PK, Harjai K. Phenotypic characters of urinary isolates of Pseudomonas aeruginosa & their association with mouse renal colonization. Indian J Med Res 2006;123:67-72.
12. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007;67:351-358
13. Macleod SM, Stickler DJ. Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol 2007;56:1549-1557
14. Stickler DJ. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: A perspective from the study of catheter biofilms. J Appl Microbiol. 2002;92(Suppl):163S-70S.
15. Hoiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001;3:23-35.
16. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995;49:711-745
17. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009;11:1034-1043
18. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 2009;5:e1000354.
19. Costerton JW, Lewandowski Z, DeBeer D, Caldwell D, Korber D, James G. Biofilms, the customized microniche. J Bacteriol 1994;176:2137-2142
20. Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002;8:881-890
21. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:34-39 (Pubitemid 32467503)
22. Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol 2005;13:7-10. (Pubitemid 40082390)
23. Parsek MR, Tolker-Nielsen T. Pattern formation in Pseudomonas aeruginosa biofilms. Curr Opin Microbiol 2008;11:560-566
24. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318-1322 (Pubitemid 29289651)
25. Davies JC, Bilton D. Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 2009;54:628-640
26. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002;56:187-209.
27. Mah T-F, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003;426:306-310
28. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Micro 2007;5:48-56. (Pubitemid 44942303)
29. Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 1999;65:3710-3713 (Pubitemid 29399007)
30. Ghigo JM. Natural conjugative plasmids induce bacterial biofilm development. Nature 2001;412:442-445
31. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-193
32. Chowdhury P, Sacks SH, Sheerin NS. Minireview: Functions of the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int 2004;66:1334-1344 (Pubitemid 39298365)
33. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology, 3rd edn. Saunders: Philadelphia, 1997:250-276
34. Curfs J, Meis M, Hoogkamp-Korstanje A. A primer on cytokines: Sources, receptors, effects, and inducers. J Clin Microbiol 1997;10:742-780 (Pubitemid 27477733)
35. Gürgöze MK, Akarsu S, Yilmaz E, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 2005;20:1445-1448 (Pubitemid 41403421)
36. Sheu JN, Chen MC, Cheng SL, Lee IC, Chen SM, Tsay GJ. Urine interleukin-1beta in children with acute pyelonephritis and renal scarring. Nephrology 2007;12:487-493 (Pubitemid 47366638)
37. Kassir K, Vargas-Shiraishi O, Zaldivar F, Berman M, Singh J, Arrieta A. Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: Potential therapeutic impact. Clin Diagn Lab Immunol 2001;8:1060-1063 (Pubitemid 33035732)
38. Dinarello CA. Interleukin-1b. Crit Care Med 2005;33:S460-2.
39. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-2118
40. Schuster A, Haarmann A, Wahn V. Cytokines in neutrophildominated airway inflammation in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 1995;252:S59-60.
41. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29:19-24.
42. Pinna A, Usai D, Sechi LA, Molicotti P, Zanetti S, Carta A. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers. Cornea 2008;27:320-326
43. Le Berre R, Nguyen S, Nowak E, et al. Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2008;14:337-343 (Pubitemid 351356524)
44. Mittal R, Chhibber S, Sharma S, Harjai K. Macrophage inflammatory protein-2, neutrophil recruitment and bacterial persistence in an experimental mouse model of urinary tract infection. Microbes Infect 2004;6:1326-1332 (Pubitemid 39539731)
45. Harjai K, Mittal R, Chhibber S, Sharma S. Contribution of Tamm- Horsfall protein to virulence of Pseudomonas aeruginosa in urinary tract infection. Microbes Infect 2005; 7:132-137
46. Mittal R, Sharma S, Chhibber S, Harjai K. Effect of macrophage secretory products on elaboration of virulence factors by planktonic and biofilm cells of Pseudomonas aeruginosa. Comp Immunol Microbiol Infect Dis 2006;29:12-26. (Pubitemid 43372684)
47. Ladd TI, Schmiel D, Nickel JC. The use of a radiorespirometric assay for testing the antibiotic sensitivity of catheter associated bacteria. J Urol 1987;138:1451-1456 (Pubitemid 18006825)
48. Mittal R, Sharma S, Chhibber S, Harjai K. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J Biomed Sci 2008;15:731-741
49. Mittal R, Sharma S, Chhibber S, Harjai K. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Microb Pathog 2008;45:323-330
50. Garg UC, Ganguly NK, Sharma S, Chakravati RN, Bhatnagar RK. Quantitative histopathological method for evaluation of experimental ascending pyelonephritis. Med Sci Res 1987;15:367-368 (Pubitemid 17083113)
51. Wills ED. Mechanism of lipid peroxide formation in animal tissues. Biochem J 1965; 99:667-676
52. Tugtepe H, Sener G, Cetinel S, Velioglu-Ogunç A, Yegen BC. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Eur J Pharmacol 2007;557:69-75. (Pubitemid 46156939)
53. Svanborg C, Bergsten G, Fischer H, et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 2006;9:33-39
54. Mak RH, Kuo HJ. Pathogenesis of urinary tract infection: An update. Curr Opin Pediatr 2006;18:148-152
55. Rudner XL, Kernacki KA, Barrett RP, Hazlett LD. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage- inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J Immunol 2000;164:6576-6582
56. Jensen ET, Kharazami A, Lam K, Costerton JW, Hoiby N. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 1990;58:2383-2385
57. Takeoka K, Ichimiya T, Yamasaki T, Nasu M. The in vitro effect of macrolides on the interaction of human polymorphonuclear leukocytes with Pseudomonas aeruginosa in biofilms. Chemotherapy 1998;44:190-197
58. Walker TS, Tomlin KL, Worthen GS, et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 2005;73:3693-3701
59. Pavlova EL, Lilova MI, Savov VM. Oxidative stress in children with kidney disease. Pediatr Nephrol 2005;20:1599-1604 (Pubitemid 41554473)
60. Bille J, Glauser MP. Protection against chronic pyelonephritis in rats by suppression of acute suppuration: Effects of colchicine and neutropenia. J Infect Dis 1982;146:220-226 (Pubitemid 12009787)
61. Meylan PR, Markert M, Bille J, Glauser MP. Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring. Infect Immun 1989;57:2196-2202 (Pubitemid 19186902)